Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Shared Processing of Language and Music.

Atherton RP, Chrobak QM, Rauscher FH, Karst AT, Hanson MD, Steinert SW, Bowe KL.

Exp Psychol. 2018 Jan;65(1):40-48. doi: 10.1027/1618-3169/a000388.

PMID:
29415645
2.

Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT Inhibition.

Au-Yeung G, Lang F, Azar WJ, Mitchell C, Jarman KE, Lackovic K, Aziz D, Cullinane C, Pearson RB, Mileshkin L, Rischin D, Karst AM, Drapkin R, Etemadmoghadam D, Bowtell DD.

Clin Cancer Res. 2017 Apr 1;23(7):1862-1874. doi: 10.1158/1078-0432.CCR-16-0620. Epub 2016 Sep 23.

3.

Effectiveness of Pharmacy Student-Led Health Education in Adults Experiencing Homelessness.

Beggs AE, Karst AC.

J Health Care Poor Underserved. 2016;27(3):954-60. doi: 10.1353/hpu.2016.0125.

PMID:
27524744
4.

Role of miR-182 in response to oxidative stress in the cell fate of human fallopian tube epithelial cells.

Liu Y, Qiang W, Xu X, Dong R, Karst AM, Liu Z, Kong B, Drapkin RI, Wei JJ.

Oncotarget. 2015 Nov 17;6(36):38983-98. doi: 10.18632/oncotarget.5493.

5.

Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer.

Lawrenson K, Li Q, Kar S, Seo JH, Tyrer J, Spindler TJ, Lee J, Chen Y, Karst A, Drapkin R, Aben KK, Anton-Culver H, Antonenkova N; Australian Ovarian Cancer Study Group, Baker H, Bandera EV, Bean Y, Beckmann MW, Berchuck A, Bisogna M, Bjorge L, Bogdanova N, Brinton LA, Brooks-Wilson A, Bruinsma F, Butzow R, Campbell IG, Carty K, Chang-Claude J, Chenevix-Trench G, Chen A, Chen Z, Cook LS, Cramer DW, Cunningham JM, Cybulski C, Dansonka-Mieszkowska A, Dennis J, Dicks E, Doherty JA, Dörk T, du Bois A, Dürst M, Eccles D, Easton DT, Edwards RP, Eilber U, Ekici AB, Fasching PA, Fridley BL, Gao YT, Gentry-Maharaj A, Giles GG, Glasspool R, Goode EL, Goodman MT, Grownwald J, Harrington P, Harter P, Hasmad HN, Hein A, Heitz F, Hildebrandt MA, Hillemanns P, Hogdall E, Hogdall C, Hosono S, Iversen ES, Jakubowska A, James P, Jensen A, Ji BT, Karlan BY, Kruger Kjaer S, Kelemen LE, Kellar M, Kelley JL, Kiemeney LA, Krakstad C, Kupryjanczyk J, Lambrechts D, Lambrechts S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, Nevanlinna H, McNeish I, Menon U, Modugno F, Moysich KB, Narod SA, Nedergaard L, Ness RB, Azmi MA, Odunsi K, Olson SH, Orlow I, Orsulic S, Weber RP, Pearce CL, Pejovic T, Pelttari LM, Permuth-Wey J, Phelan CM, Pike MC, Poole EM, Ramus SJ, Risch HA, Rosen B, Rossing MA, Rothstein JH, Rudolph A, Runnebaum IB, Rzepecka IK, Salvesen HB, Schildkraut JM, Schwaab I, Sellers TA, Shu XO, Shvetsov YB, Siddiqui N, Sieh W, Song H, Southey MC, Sucheston L, Tangen IL, Teo SH, Terry KL, Thompson PJ, Timorek A, Tsai YY, Tworoger SS, van Altena AM, Van Nieuwenhuysen E, Vergote I, Vierkant RA, Wang-Gohrke S, Walsh C, Wentzensen N, Whittemore AS, Wicklund KG, Wilkens LR, Woo YL, Wu X, Wu AH, Yang H, Zheng W, Ziogas A, Monteiro A, Pharoah PD, Gayther SA, Freedman ML.

Nat Commun. 2015 Sep 22;6:8234. doi: 10.1038/ncomms9234.

6.

YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells.

Hua G, Lv X, He C, Remmenga SW, Rodabough KJ, Dong J, Yang L, Lele SM, Yang P, Zhou J, Karst A, Drapkin RI, Davis JS, Wang C.

Oncogene. 2016 Apr 28;35(17):2247-65. doi: 10.1038/onc.2015.288. Epub 2015 Sep 14.

7.

Stathmin 1 and p16(INK4A) are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma.

Novak M, Lester J, Karst AM, Parkash V, Hirsch MS, Crum CP, Karlan BY, Drapkin R.

Gynecol Oncol. 2015 Oct;139(1):104-11. doi: 10.1016/j.ygyno.2015.07.100. Epub 2015 Jul 20.

8.

Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci.

Coetzee SG, Shen HC, Hazelett DJ, Lawrenson K, Kuchenbaecker K, Tyrer J, Rhie SK, Levanon K, Karst A, Drapkin R, Ramus SJ; Ovarian Cancer Association Consortium, The Consortium of Investigators of Modifiers of BRCA1/2, Couch FJ, Offit K, Chenevix-Trench G, Monteiro AN, Antoniou A, Freedman M, Coetzee GA, Pharoah PD, Noushmehr H, Gayther SA; Ovarian Cancer Association Consortium The Consortium of Investigators of Modifiers of BRCA1/2.

Hum Mol Genet. 2015 Jul 1;24(13):3595-607. doi: 10.1093/hmg/ddv101. Epub 2015 Mar 24.

9.

The unique needs of older adults readmitted to the hospital.

Hasan L, Singh M, Khan A, Lung J, Malone M, Karst A.

J Am Geriatr Soc. 2014 Jul;62(7):1378-80. doi: 10.1111/jgs.12918. No abstract available.

PMID:
25039506
10.

Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance.

Davidowitz RA, Selfors LM, Iwanicki MP, Elias KM, Karst A, Piao H, Ince TA, Drage MG, Dering J, Konecny GE, Matulonis U, Mills GB, Slamon DJ, Drapkin R, Brugge JS.

J Clin Invest. 2014 Jun;124(6):2611-25. doi: 10.1172/JCI69815. Epub 2014 Apr 24.

11.

In vivo multiplexed interrogation of amplified genes identifies GAB2 as an ovarian cancer oncogene.

Dunn GP, Cheung HW, Agarwalla PK, Thomas S, Zektser Y, Karst AM, Boehm JS, Weir BA, Berlin AM, Zou L, Getz G, Liu JF, Hirsch M, Vazquez F, Root DE, Beroukhim R, Drapkin R, Hahn WC.

Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):1102-7. doi: 10.1073/pnas.1311909111. Epub 2014 Jan 2.

12.

Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers.

Karst AM, Jones PM, Vena N, Ligon AH, Liu JF, Hirsch MS, Etemadmoghadam D, Bowtell DD, Drapkin R.

Cancer Res. 2014 Feb 15;74(4):1141-52. doi: 10.1158/0008-5472.CAN-13-2247. Epub 2013 Dec 23.

13.

Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.

Perets R, Wyant GA, Muto KW, Bijron JG, Poole BB, Chin KT, Chen JY, Ohman AW, Stepule CD, Kwak S, Karst AM, Hirsch MS, Setlur SR, Crum CP, Dinulescu DM, Drapkin R.

Cancer Cell. 2013 Dec 9;24(6):751-65. doi: 10.1016/j.ccr.2013.10.013.

14.

Primary culture and immortalization of human fallopian tube secretory epithelial cells.

Karst AM, Drapkin R.

Nat Protoc. 2012 Sep;7(9):1755-64. doi: 10.1038/nprot.2012.097. Epub 2012 Aug 30.

PMID:
22936217
15.

Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4.

Ren Y, Cheung HW, von Maltzhan G, Agrawal A, Cowley GS, Weir BA, Boehm JS, Tamayo P, Karst AM, Liu JF, Hirsch MS, Mesirov JP, Drapkin R, Root DE, Lo J, Fogal V, Ruoslahti E, Hahn WC, Bhatia SN.

Sci Transl Med. 2012 Aug 15;4(147):147ra112. doi: 10.1126/scitranslmed.3003778.

16.
17.

The new face of ovarian cancer modeling: better prospects for detection and treatment.

Karst AM, Drapkin R.

F1000 Med Rep. 2011;3:22. doi: 10.3410/M3-22. Epub 2011 Nov 1.

18.

Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas.

Karst AM, Levanon K, Duraisamy S, Liu JF, Hirsch MS, Hecht JL, Drapkin R.

Gynecol Oncol. 2011 Oct;123(1):5-12. doi: 10.1016/j.ygyno.2011.05.021. Epub 2011 Jun 17.

19.

Modeling high-grade serous ovarian carcinogenesis from the fallopian tube.

Karst AM, Levanon K, Drapkin R.

Proc Natl Acad Sci U S A. 2011 May 3;108(18):7547-52. doi: 10.1073/pnas.1017300108. Epub 2011 Apr 18.

20.

The tellurophosphate K(4)P(8)Te(4): phase-change properties, exfoliation, photoluminescence in solution and nanospheres.

Chung I, Song JH, Kim MG, Malliakas CD, Karst AL, Freeman AJ, Weliky DP, Kanatzidis MG.

J Am Chem Soc. 2009 Nov 11;131(44):16303-12. doi: 10.1021/ja907273g.

PMID:
19845382
21.

Ovarian cancer pathogenesis: a model in evolution.

Karst AM, Drapkin R.

J Oncol. 2010;2010:932371. doi: 10.1155/2010/932371. Epub 2009 Sep 6.

22.

Nuclear factor kappa B subunit p50 promotes melanoma angiogenesis by upregulating interleukin-6 expression.

Karst AM, Gao K, Nelson CC, Li G.

Int J Cancer. 2009 Jan 15;124(2):494-501. doi: 10.1002/ijc.23973.

23.

Synthesis of a family of solids through the building-block approach: a case study with Ag(+) substitution in the ternary Na-Ge-Se system.

Choudhury A, Strobel S, Martin BR, Karst AL, Dorhout PK.

Inorg Chem. 2007 Mar 19;46(6):2017-27. Epub 2007 Feb 16.

PMID:
17302403
24.
25.

BH3-only proteins in tumorigenesis and malignant melanoma.

Karst AM, Li G.

Cell Mol Life Sci. 2007 Feb;64(3):318-30. Review.

PMID:
17192811
26.
27.

[P6Se12]4-: a phosphorus-rich selenophosphate with low-valent P centers.

Chung I, Karst AL, Weliky DP, Kanatzidis MG.

Inorg Chem. 2006 Apr 3;45(7):2785-7.

PMID:
16562935
28.

PUMA expression is significantly reduced in human cutaneous melanomas.

Karst AM, Dai DL, Martinka M, Li G.

Oncogene. 2005 Feb 3;24(6):1111-6.

PMID:
15690057
29.

'Dosimetric breast size': a new and useful parameter for the prediction of local recurrence after breast conservative treatment.

Cutuli B, Velten M, Karst A, Jaeck D, Renaud R, Rodier JF.

Eur J Cancer. 1997 Dec;33(14):2432-4.

PMID:
9616294
30.

Apolipoprotein E genotypes in Parkinson's disease with and without dementia.

Koller WC, Glatt SL, Hubble JP, Paolo A, Tröster AI, Handler MS, Horvat RT, Martin C, Schmidt K, Karst A, et al.

Ann Neurol. 1995 Feb;37(2):242-5.

PMID:
7847865
31.
32.

[Critical investigations of preoperative intestinal disinfection with special reference to neomycin and bacitracin].

KARST A, HEIN H.

Bruns Beitr Klin Chir. 1958;197(4):469-87. English, German. No abstract available.

PMID:
13618671
33.

[Operative therapy of the old luxation of radius head].

KARST A.

Chirurg. 1953 May;24(5):217-8. Undetermined Language. No abstract available.

PMID:
13082615

Supplemental Content

Support Center